16,284 resources
Start Prev Rows 6600 - 6800 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date |
|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.132 | Findings Related to Medication Management, Alcohol Use | active | 2019-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.133 | Findings Related to Medication Management, Caffeine Use | active | 2019-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.134 | Interventions Related to Education, Diet | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.136 | Findings Related to Medication Management, Exercise | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.137 | Interventions Related to Education, Behavior | active | 2023-12 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.138 | Findings Related to Medication Management, Diet | active | 2021-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.139 | Status of Care Goal | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.140 | Findings Related to Medication Management, Illicit Drug Use | active | 2020-09 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.141 | Interventions Related to Administration, Immunizations | active | 2021-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.142 | Interventions Related to Care Coordination, Communication Needs | active | 2020-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.144 | Findings Related to Medication Management, Life Event | active | 2023-12 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.145 | Interventions Related to Medication Management, Device or Equipment Fitting | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.146 | Findings Related to Medication Management, Immunizations | active | 2021-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.148 | Findings Related to Medication Management, Cultural Beliefs | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.149 | Findings Related to Medication Management, Tobacco Use | active | 2023-12 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.150 | Interventions Related to Medication Regimen, Continue Medication | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.151 | Encounter Type | active | 2020-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.152 | Encounter Class | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.156 | Allergy/Intolerance Severity | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.160 | Allergy/Intolerance Manifestation | active | 2019-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.162 | Allergy/Intolerance Substance & Negation | active | 2022-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.163 | Allergy/Intolerance Negation | active | 2023-12 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.165 | Interventions Related to Care Coordination, Benefit Management | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.166 | Interventions Related to Administration | active | 2022-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.167 | Interventions Related to Administration, Medications | active | 2020-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.168 | Findings Related to Medication Management, Eating Habits | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.169 | Findings Related to Medication Management, Tobacco Exposure | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.170 | Interventions Related to Care Coordination | active | 2022-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.176 | Interventions Related to Medication Management, Information Gathering | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.177 | Interventions Related to Medication Management, Care Planning | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.178 | Interventions Related to Medication Management, Documentation | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.179 | Allergy/Intolerance Substance, Food | active | 2023-12 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.180 | Allergy/Intolerance Substance, Environmental | active | 2023-12 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.182 | Encounter Reason | active | 2020-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.218 | Reasons for Interventions Related to Medication Management, Discontinue Medication | active | 2021-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.224 | Social Determinants of Health Problem Observation | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.225 | Laboratory results that are used in medication management | active | 2020-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.230 | Maternity Health Interventions Value Set | active | 2024-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.231 | Social Determinants of Health Interventions | active | 2024-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.232 | Maternity Health Findings | active | 2024-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.233 | Reason Medication Discontinued Lack of Indication | active | 2024-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.234 | Reason Medication Discontinued Lack of Effectiveness | active | 2024-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.235 | Reason Medication Discontinued Safety Issue Occurred | active | 2024-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.236 | Reason Medication Discontinued Compliance Issue other than cost | active | 2024-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.237 | Recommendation to Resolve Medication Therapy Problem | active | 2024-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.239 | Reason Medication Discontinued Patient Unable to Afford | active | 2024-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.240 | Medication Lists | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.3 | Findings Related to Medication Management, Transitions Between Health Care Settings | active | 2019-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.35 | Interventions Related to Medication Management, Comprehensive Medication Review | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.5 | Reasons for Interventions Related to Medication Management, Unnecessary Therapy | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.55 | Reasons for Interventions Related to Medication Management, Adherence | active | 2024-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.56 | Findings Related to Medication Management, Multiple Providers | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.6 | Reasons for Interventions Related to Medication Management, New or Additional Therapy Required | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.60 | Findings Related to Medication Management, Health Literacy | active | 2021-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.61 | Findings Related to Medication Management | active | 2022-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.7 | Reasons for Interventions Related to Medication Management, Ineffective Therapy | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.8 | Reasons for Interventions Related to Medication Management, Dose Too Low | active | 2019-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.83 | Assessments Related to Medication Management, General Assessments | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.84 | Assessments Related to Medication Management | active | 2022-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.85 | Assessments Related to Medication Management, Assessments Using Assessment Scales | active | 2020-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.86 | Interventions Related to Medication Regimen, Monitoring | active | 2023-12 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.88 | Interventions Related to Care Coordination, Referrals to Other Providers | active | 2023-12 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.89 | Interventions Related to Care Coordination, Referrals for Specific Services | active | 2023-12 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.9 | Reasons for Interventions Related to Medication Management, Dose Too High | active | 2019-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.90 | Recommendations Related to Medication Regimen, Continue Medication | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.91 | Recommendations Related to Medication Regimen, Initiate Medication | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.92 | Recommendations Related to Medication Regimen, Change Medication | active | 2021-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.93 | Recommendations Related to Medication Regimen, Change Medication Dose | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.94 | Recommendations Related to Medication Regimen, Change Medication Dosage Form | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.95 | Recommendations Related to Medication Regimen, Change Medication Course | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.97 | Recommendations Related to Medication Regimen, Change Medication Dosing Interval | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.98 | Recommendations Related to Medication Regimen, Discontinue Medication | active | 2017-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.99 | Recommendations Related to Medication Regimen, Monitoring | active | 2021-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1099.12 | Medication Route | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1099.24 | Extended Pregnancy Status | active | 2023-07 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1099.33 | External Cause of Injury/Morbidity | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1099.35 | Arthritis Feedback Types (SNOMED) | active | 2019-12 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1099.36 | Arthritis Feedback Types (LOINC) | active | 2025-05 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1099.45 | Bidirectional Services eReferral Type | active | 2025-05 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1099.46 | Bidirectional Services eReferral Reason | active | 2025-05 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1099.50 | Transport vehicle type | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1099.54 | Specimen type | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1099.55 | At Home In Vitro Patient Questions | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1099.58 | Acute COVID 19 Diagnosis | active | 2023-07 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1102.1 | Case Management for Behavioral Health | active | 2021-12 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1102.63 | Case Management for Behavioral Health | active | 2021-12 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1102.64 | Case Management for Behavioral Health | active | 2021-12 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.124 | Follow Up Within 6 Months | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.125 | Follow Up Within 6 Months | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.126 | Bone Scan | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.127 | Bone Scan | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.15 | Hospice Care Ambulatory | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.175 | Office and Wellness Visits for General Screening | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.176 | Office and Wellness Visits for General Screening | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.177 | Office and Wellness Visits for General Screening | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.178 | Office and Wellness Visits for General Screening | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.28 | Non Acute Encounter Codes CPT | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.29 | Non Acute Encounter Codes HCPCS | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.31 | Bleeding Event Diagnosis Codes ICD9 | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.78 | Statin Associated Muscle Symptoms | active | 2021-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.84 | Statin Associated Muscle Symptoms | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.85 | Statin Associated Muscle Symptoms | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1108.99 | Underweight | active | 2022-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.11 | Cornual Ectopic Pregnancy | active | 2021-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.12 | Cornual Ectopic Pregnancy | active | 2021-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.13 | Perforation of Uterus | active | 2021-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.14 | Perforation of Uterus | active | 2021-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.15 | Uterine Rupture | active | 2021-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.16 | Uterine Rupture | active | 2021-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.17 | Transabdominal Cerclage | active | 2021-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.18 | Transabdominal Cerclage | active | 2022-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.2 | Transabdominal Cerclage | active | 2021-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.21 | Intravenous or Intraarterial Thrombolytic tPA Therapy Prior to Arrival | active | 2021-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.23 | Intensive Care Unit | active | 2021-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.24 | Uterine Horn | active | 2021-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.25 | Metroplasty | active | 2021-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.3 | Medical Induction of Labor | active | 2021-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.35 | Placenta Previa | active | 2021-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.36 | Placenta Accreta Spectrum Previa or Vasa Previa | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.37 | Placenta Accreta Spectrum Previa or Vasa Previa | active | 2023-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.38 | Outpatient Surgery Service | active | 2019-04 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.41 | Statin Allergen | active | 2022-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.42 | Statin Allergen | active | 2021-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.50 | Rivaroxaban for VTE Prophylaxis | active | 2022-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.51 | Prasugrel | active | 2021-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.52 | Pharmacological Contraindications For Antithrombotic Therapy | active | 2022-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.53 | Acute Renal Failure | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.54 | Total Parenteral Nutrition | active | 2021-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.55 | Intravenous Thrombolytic tPA Therapy | active | 2021-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.56 | Intraarterial Thrombolytic tPA Therapy | active | 2021-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.57 | Ischemic Stroke Thrombosis | active | 2021-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.58 | Ischemic Stroke Thrombosis | active | 2021-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.59 | Ischemic Stroke Other | active | 2021-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.60 | Ischemic Stroke Other | active | 2021-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.61 | Antithrombotic Therapy Antiplatelet | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.62 | Antithrombotic Therapy for Ischemic Stroke | active | 2021-04 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.63 | Present On Admission is Yes or Exempt | active | 2022-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.64 | Application of Venous Foot Pumps | active | 2022-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.65 | Application of Intermittent Pneumatic Compression Devices | active | 2022-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.66 | Application of Graduated Compression Stockings | active | 2022-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.67 | 20 to 42 Plus Weeks Gestation | active | 2023-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.68 | 37 to 42 Plus Weeks Gestation | active | 2023-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.69 | 37 to 38 Weeks Gestation | active | 2023-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.70 | 20 to 42 Plus Weeks Gestation | active | 2023-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.71 | 20 to 42 Plus Weeks Gestation | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.72 | 37 to 42 Plus Weeks Gestation | active | 2023-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.73 | 37 to 42 Plus Weeks Gestation | active | 2023-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.74 | 37 to 38 Weeks Gestation | active | 2023-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.75 | 37 to 38 Weeks Gestation | active | 2023-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.76 | History of Atrial Ablation | active | 2022-11 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.77 | Placenta Accreta Spectrum Previa or Vasa Previa | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1110.78 | Placenta Previa | active | 2023-11 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.143 | Observation Services | active | 2021-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.159 | All Primary and Secondary Cancer | active | 2023-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.161 | All Primary and Secondary Cancer | active | 2022-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.163 | Emergency Department Evaluation | active | 2020-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.164 | Admit Inpatient | active | 2021-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.171 | Opioid Use Disorder | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.173 | Sickle Cell Disease with and without Crisis SNOMED | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.174 | Sickle Cell Disease with and without Crisis ICD | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.175 | Sickle Cell Disease with and without Crisis | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.176 | Opioid Medication Assisted Treatment (MAT) HCPCS | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.177 | Opioid Medication Assisted Treatment (MAT) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.178 | Cancer Related Pain ICD 10 | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.179 | Cancer Related Pain SNOMED | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1111.180 | Cancer Related Pain | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.10 | Care Experience Preferences at End of Life LOINC | active | 2024-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.12 | Healthcare Agent Ordinality | active | 2020-12 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.14 | ADIClauseTypeVS | active | 2022-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.17 | Preconditions for Treatment Preferences | active | 2024-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.22 | Advance Directive Document Types | active | 2024-07 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.23 | AD Conditions and Prognosis Scenarios | active | 2023-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.26 | Healthcare Agent or Advisor Indicator | active | 2024-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.27 | Initial Treatment portable medical order options | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.28 | Cardiopulmonary Resuscitation Order Options | active | 2024-09 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.30 | Cardiopulmonary Resuscitation Order Procedures | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.31 | Cardiopulmonary Resuscitation Procedures Grouping | active | 2024-09 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.32 | Additional Portable Medical Order Procedures | active | 2025-04 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.33 | Initial Treatment Portable Medical Order Procedures Grouping | active | 2024-09 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.34 | Additional portable medical order Procedures Grouping | active | 2024-09 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.35 | Medically Assisted Nutrition Order Options | active | 2024-09 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.36 | Medically Assisted Nutrition Portable Medical Order Procedures Grouping | active | 2024-09 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.37 | Healthcare Agent Powers | active | 2024-11 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.38 | Personal Health Goal Options LOINC | active | 2025-03 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.40 | Portable Medical Order Document Types | active | 2025-04 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.41 | Advance Healthcare Directive Document Types Grouper | active | 2025-04 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1115.8 | Treatment Intervention Preferences at End of Life LOINC | active | 2025-04 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1116.1 | Rituximab Injectable | active | 2024-12 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1116.100 | Pathological M Stage M1c | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1116.101 | Pathological N Stage N3 | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1116.102 | N Stage pN1a | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1116.103 | N Stage pN1b | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1116.105 | Pathological N Stage pN1mi | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1116.106 | Pathological N Stage N2b | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1116.107 | Pathological N Stage N2a | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1116.108 | Pathological N Stage N2 | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1116.109 | Pathological N Stage N1b | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1116.110 | Pathological N Stage N1a | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1116.112 | Pathological N Stage N0 | active | 2024-08 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1116.114 | Pathological T Stage T4d | active | 2024-08 |
FHIR